Manipulation of cellular redox parameters for improving therapeutic responses in B-cell lymphoma and multiple myeloma. - Wikidata - awgldk - TriplyDB

Manipulation of cellular redox parameters for improving therapeutic responses in B-cell lymphoma and multiple myeloma.

Manipulation of cellular redox parameters for improving therapeutic responses in B-cell lymphoma and multiple myeloma.

http://www.wikidata.org/entity/Q37940343

about

A novel model of chronic wounds: importance of redox imbalance and biofilm-forming bacteria for establishment of chronicity Copper-zinc superoxide dismutase-mediated redox regulation of bortezomib resistance in multiple myeloma.Drug metabolism and clearance system in tumor cells of patients with multiple myeloma Interleukin-6 counteracts therapy-induced cellular oxidative stress in multiple myeloma by up-regulating manganese superoxide dismutase Combination chemotherapy increases cytotoxicity of multiple myeloma cells by modification of nuclear factor (NF)-κB activity.Scavenger receptor class A member 3 (SCARA3) in disease progression and therapy resistance in multiple myeloma Oxidative stress in oncohematologic diseases: an update.Oxidative stress and proteasome inhibitors in multiple myeloma.Human MutT homologue 1 mRNA overexpression correlates to poor response of multiple myeloma.Cyclin D1 unbalances the redox status controlling cell adhesion, migration, and drug resistance in myeloma cells.Zinc status alters growth and oxidative stress responses in rat hepatoma cells.The metabolic regulator PGC-1α links anti-cancer cytotoxic chemotherapy to reactivation of hepatitis B virus.Characteristics of BAFF and APRIL factor expression in multiple myeloma and clinical significance.Arsenic Trioxide Induces Apoptosis via Specific Signaling Pathways in HT-29 Colon Cancer Cells.Oxidative stress markers and mitochondrial antioxidant enzyme expression are increased in aggressive Hodgkin lymphomas.

P2860

Q21559454-55E6E706-E714-4FF4-9216-70330730124C Q35024457-3F20C494-B759-4F4C-8CA0-4F13833ABF4C Q35742560-8B03A8BE-27D8-4F63-A212-3F5E709DC7BC Q36002035-0E4B363C-6585-44B4-9CEE-4B62577A198C Q36589122-1B844070-FE99-4548-85EF-56A5CCA5CB2D Q36980287-2414D113-C0CF-493A-AFD0-9A609B7AE016 Q38115588-B471B522-462B-4757-8738-87D74C18A54B Q38717135-BF617A25-92F6-4DF7-976E-D7896B4BC902 Q38730889-86C7FC2F-2590-4105-9AED-18E002E83E31 Q38765278-0F16A5F5-8CC5-4CF3-A6D9-49F07C2C45AC Q39044806-A132408C-269E-4A72-886E-2A79F27AA0D5 Q39227989-72DED2D2-A0F6-4993-A3AE-0216BB21D468 Q41612443-6D9CEE40-AB4A-4FD2-9FF5-34C5279F9EF7 Q41674676-8C816237-809B-41A8-A224-BDADC3425B3C Q46910326-3BAF5176-FA46-4F6C-BC33-98E95C3D4392

P2860

Manipulation of cellular redox parameters for improving therapeutic responses in B-cell lymphoma and multiple myeloma.

http://www.wikidata.org/entity/Q37940343

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Manipulation of cellular redox ...... lymphoma and multiple myeloma.

@en

Manipulation of cellular redox ...... lymphoma and multiple myeloma.

@nl

type

label

Manipulation of cellular redox ...... lymphoma and multiple myeloma.

@en

Manipulation of cellular redox ...... lymphoma and multiple myeloma.

@nl

prefLabel

Manipulation of cellular redox ...... lymphoma and multiple myeloma.

@en

Manipulation of cellular redox ...... lymphoma and multiple myeloma.

@nl

P1433

Q37940343-218EF554-68D3-4CB1-84C2-951BC204649B

P1476

Q37940343-FA18CF6E-6BA0-4740-9DCB-B5C71543AC1A

P2093

Q37940343-0862CE63-F54B-4F4B-8002-D6CE81ED1C02

Q37940343-B8BAD9D1-4A4E-4A57-9436-4D5D3C6679B5

Q37940343-BAC3F18B-B26F-4EB2-B011-78212904FA50

P2860

Q37940343-003F424F-B23C-494A-B46F-2E7B7C89DAA6

Q37940343-018B78D6-9894-4D25-BED5-4210246FEE95

Q37940343-02BEAE7E-007E-4F13-B376-C8501DDA4B1F

Q37940343-04020E4B-C2F6-4B0D-9F25-5B08FAB84DCE

Q37940343-0B15C993-0A72-425F-A0D8-6BE39123998A

Q37940343-0D64E16B-A1E1-47FB-A0D5-38B6C4B861BF

Q37940343-0D8F8A87-7254-4C3D-BCAB-63EFBC0C5E9B

Q37940343-0E9D68A8-F95E-4118-BAA4-125F59F84B61

Q37940343-17CFCA3D-3A56-4AAC-8CA8-5314E1F3A2F1

Q37940343-1D662D1A-AF88-4AC0-9A08-8C567604A6D0

P304

Q37940343-BBBE6B1D-1FE4-4E0D-893E-6986C31A2BC2

P31

Q37940343-1FCB5700-1ED6-49F6-AFAA-BBE1675ECC8E

P356

Q37940343-70AF7660-221B-4619-93E7-B96277E5C85C

P433

Q37940343-05A08EB5-0850-4AF6-B5D8-DC52B5EF7C2E

P478

Q37940343-13D4791D-4B51-41A3-8EF9-F77C58FD0574

P577

Q37940343-E498B3DC-0014-4DA5-9725-B2CC7D0E8275

P5875

Q37940343-B489C776-37B0-4D07-9E4E-BB619AA96AB1

P698

Q37940343-A946E643-E0E7-4617-8744-CEF3D305ECA5

P932

Q37940343-3618DB41-C48E-427C-A501-BFFCAEE0CC57

P356

P1433

Journal of Cellular Biochemistry

P1476

Manipulation of cellular redox ...... lymphoma and multiple myeloma.

@en

P2093

Apollina Goel

http://www.w3.org/2001/XMLSchema#string

Douglas R Spitz

http://www.w3.org/2001/XMLSchema#string

George J Weiner

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Oxidants, oxidative stress and the biology of ageing

Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple

Production of large amounts of hydrogen peroxide by human tumor cells

2-Methoxyestardiol and bortezomib/proteasome-inhibitor overcome dexamethasone-resistance in multiple myeloma cells by modulating Heat Shock Protein-27.

Oligodeoxynucleotide CpG 7909 delivered as intravenous infusion demonstrates immunologic modulation in patients with previously treated non-Hodgkin lymphoma.

A phase I study of samarium lexidronam/bortezomib combination therapy for the treatment of relapsed or refractory multiple myeloma.

Glucose deprivation-induced oxidative stress in human tumor cells. A fundamental defect in metabolism?

Phase II study of arsenic trioxide and ascorbic acid for relapsed or refractory lymphoid malignancies: a Wisconsin Oncology Network study

The emerging role of reactive oxygen species in cancer therapy.

P304

419-425

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JCB.23387

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

113

http://www.w3.org/2001/XMLSchema#string

P577

2012-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51677141

http://www.w3.org/2001/XMLSchema#string

P698

21956712

http://www.w3.org/2001/XMLSchema#string

P932

3374635

http://www.w3.org/2001/XMLSchema#string